Director, U.S. Policy – 340B Program Strategy

Company Description

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.

Job Description

The Director, U.S. Policy – 340B Program Strategy will lead the development and execution of AbbVie's U.S. Policy & Analytics’ strategy related to the 340B Drug Pricing Program across federal and state policy environments. This role will serve as a primary subject-matter expert, strategic architect, and external-facing leader within the U.S. Policy & Analytics team, driving AbbVie's approach to 340B policy amid a rapidly evolving legislative, regulatory, and litigation landscape.

The Director will not only monitor and analyze policy developments but proactively shape the external environment — cultivating relationships with key policymakers and stakeholders as well as positioning AbbVie as a credible and constructive voice in 340B reform debates. This role will translate complex regulatory and legislative dynamics into forward-looking strategic insights, lead the development of coordinated advocacy campaigns, and drive cross-functional alignment on AbbVie's priorities related to patient access, affordability, and program integrity.

This role requires a seasoned policy strategist with deep 340B expertise, executive presence, and a demonstrated track record of influencing policy outcomes.

Responsibilities

• Lead the development and execution of AbbVie's enterprise 340B policy strategy across federal and state arenas, identifying short- and long-term opportunities to shape the legislative, regulatory, and litigation environment in alignment with AbbVie's business and patient access priorities.
• Develop and maintain a comprehensive 340B policy roadmap that anticipates emerging threats and opportunities, informs internal decision-making, and guides coordinated advocacy efforts.
• Translate complex policy developments into clear strategic recommendations for senior leadership, including trade-off analyses and scenario planning for key policy outcomes.
• Support internal governance and cross-functional alignment on AbbVie's 340B positions, ensuring consistent messaging and coordinated action across Government Affairs, Market Access, Legal, Pricing, Commercial, the 340B Center of Excellence, and Patient Access teams.

• Build and manage relationships with key external stakeholders — including policymakers, regulators, patient advocacy groups, health systems, and industry peers — to advance policy solutions that promote program integrity, transparency, and sustainability.
• Lead AbbVie's participation in industry coalitions and stakeholder working groups focused on 340B reform, helping to shape coalition positions and drive coordinated advocacy strategies.
• Represent AbbVie at policy forums, congressional briefings, regulatory comment processes, and public stakeholder engagements as a credible and authoritative voice on 340B issues.

• Monitor, analyze, and interpret federal and state 340B developments, including legislation, regulatory proposals, litigation activity, and administrative guidance, and assess their business, patient access, and operational implications.
• Lead the development of high-quality policy materials including white papers, briefing documents, legislative concepts, regulatory comment letters, op-eds, and stakeholder communications that articulate AbbVie's 340B positions with clarity and credibility.
• Develop and maintain external-facing policy narratives and messaging frameworks that can be deployed across a range of audiences and advocacy channels.

Qualifications

• Minimum 10+ years of experience in health policy, government affairs, or a related field, with significant time spent in roles requiring direct external engagement with policymakers or regulators.
• Demonstrated expertise in the 340B Drug Pricing Program, including program structure, covered entity and manufacturer dynamics, stakeholder landscape, and current reform debates.
• Proven track record of influencing policy outcomes through direct engagement with Congress, fed